The CD44, CD24, HER2, and epithelial cell adhesion molecule (EpCAM) expression on BT474 and SK-BR-3 tumor cells was assessed by flow cytometry as a function of tumor treatment (Supplementary Figure S4A). Here, EPCAM is linked to neoplasm.